Cancers | Highly Cited Special Issues in 2022–2023 Related to Molecular Cancer Biology
We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to molecular cancer biology in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.
The list of relevant Special Issues is provided below:
|
“Novel Biomarkers and Molecular Targets in Cancer” |
“Incorporating DNA Damage Response (DDR) Mechanisms in Cancer Systems” |
|
|
|
|
“Hippo Signaling Pathway in Cancers” |
“Updates on Molecular Targeted Therapies for CNS Tumors” |
|
|
|
|
“Thyroid Cancers” |
“Molecular Pathogenesis of Cervical Cancer” |
|
|
|
|
“Breast Cancer: Novel Histological and Molecular Markers for Diagnosis, Prognosis, Therapeutic Prediction, and Drug Resistance” |
“Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)” |
|
|
|
You are invited to view and submit relevant papers and proposals for some related Special Issues to the journal Cancers at the following links:
- https://www.mdpi.com/journal/cancers;
- https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.
Cancers Editorial Office